Case Involving Access to Abortion Pill Moves to Appeals Court
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
WEDNESDAY, May 17, 2023 -- A ruling on the abortion pill mifepristone will be one step closer Wednesday when three federal judges hear arguments in the case.
The three judges at the 5th U.S. Circuit Court of Appeals in New Orleans have a history of supporting abortion restrictions, the Associated Press reported. They aren’t expected to rule immediately.
In November, abortion opponents in Texas filed a lawsuit in federal court, challenging the U.S. Food and Drug Administration's approval of the drug in 2000. On April 7, a U.S. District Judge Matthew Kacsmaryk issued a ruling that would have revoked approval of mifepristone. Kacsmaryk was nominated to the court by former President Donald Trump.
An appeal by the Biden administration and drugmaker Danco Laboratories led to a partial block of the ruling.
An appellate panel ruled that the abortion opponents were barred by time limits from challenging the 2000 approval. But it allowed limitations on changes the FDA had made since then, including on mailing the drug, according to the AP.
The U.S. Supreme Court put the lower court rulings on hold, pending appeal. That is likely to allow existing access to mifepristone into next year.
Mifepristone is one half of the two-pill medication abortion regimen. The other medication, misoprostol, could be used alone if courts restrict mifepristone, though it is less effective when used that way.
The FDA has revised its initial approval of mifepristone in recent years. It reduced the dosage needed to safely end pregnancy, allowed pills to be shipped by mail and said an in-person doctor visit was not required. It also extended this option to 10 weeks of pregnancy. Previously, use of mifepristone was allowed only up to seven weeks of pregnancy, the AP reported.
Sources
- Associated Press
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
Birth Control Pill Might Lower Odds for Sports Injuries
WEDNESDAY, April 17, 2024 -- Active women using the pill appear to receive an added bonus from their birth control, a new study says. These women are less likely to suffer...
Big Rise in Young Adults Undergoing Permanent Sterilization After Dobbs Decision
FRIDAY, April 12, 2024 -- An increasing number of young men and women have decided they never want parenthood in the wake of the Dobbs decision revoking the constitutional right...
Florida Supreme Court Backs Abortion Ban, But Allows Referendum on Issue
TUESDAY, April 2, 2024 -- In two separate rulings on Monday, the Florida Supreme Court backed that state's abortion ban while also allowing a proposed constitutional amendment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.